Loading insider details...
Beta
Latest Form 4 (Apr 3, 2026): Grant/Award of 56,000 CAMP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 3, 2026 | Camp4 Therapeutics Corp (CAMP) | Grant/Award | 56,000 | n/a |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 133,977 | n/a |
| Jan 23, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 1,807 | $130.9K |
| Jan 9, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 1,974 | $142.6K |
| Aug 15, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 30,914 | $1.32M |
| Mar 21, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 7,935 | $246.4K |
| Jan 24, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 1,622 | $46.4K |
| Jan 9, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 25,000 | n/a |
| Dec 19, 2024 | Avidity Biosciences, Inc. (RNA) | Sale | 11,151 | $364.2K |
| Nov 8, 2024 | Avidity Biosciences, Inc. (RNA) | Sale | 27,262 | $1.26M |